The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signaling

Erna Raja1, Kalliopi Tzavlaki2, Robin Vuilleumier3

  • 1Ludwig Institute for Cancer Research, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Oncotarget
|December 25, 2015
PubMed

Insights

The protein kinase LKB1 interacts with BMP receptors, suppressing their function. This discovery reveals a new mechanism impacting cell growth, differentiation, and lung cancer development.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • Liver kinase B1 (LKB1) is a key regulator of cell metabolism and growth, with roles in various cancers.
  • Bone morphogenetic protein (BMP) signaling is crucial for cell differentiation and maintaining tissue homeostasis.
  • Dysregulation of BMP signaling is linked to developmental abnormalities and diseases, including cancer.

Purpose of the Study:

  • To investigate the interaction between LKB1 and BMP type I receptors.
  • To elucidate the role of LKB1 in regulating BMP signaling pathways.
  • To explore the implications of LKB1-BMP interactions in lung cancer pathogenesis.

Main Methods:

  • Biochemical assays to demonstrate physical interaction between LKB1 and BMP type I receptors.
  • Functional studies in cell culture and Drosophila models to assess BMP signaling modulation.
  • Analysis of LKB1 expression and Smad1 phosphorylation in non-small cell lung cancer patient cohorts.

Main Results:

  • LKB1 physically interacts with BMP type I receptors and, with Smad7, promotes receptor downregulation.
  • LKB1 suppresses BMP-induced osteoblast differentiation and influences BMP signaling in Drosophila.
  • A negative correlation was observed between LKB1 expression and Smad1 phosphorylation in lung cancer patients, particularly adenocarcinomas.
  • LKB1 loss-of-function mutations correlate with high BMP2 expression and genes involved in apoptosis and migration in lung cancer.

Conclusions:

  • LKB1 acts as a novel regulator of BMP type I receptors, influencing their stability and signaling output.
  • This LKB1-mediated BMP receptor regulation pathway has significant implications for understanding physiological organogenesis.
  • The findings highlight a new mechanism contributing to lung cancer development and progression, involving LKB1, BMP signaling, and associated gene expression.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.2K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
20.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K